Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4523 On Other Exchanges
Symbol
Exchange
4523 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Akira Fujiyoshi

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Mr. Akira Fujiyoshi served as the Vice President of Corporate Communications & Investor Relations of Eisai Co., Ltd., since June 2006. Mr. Fujiyoshi joined the Eisai Co. Ltd. in April 1976. He served as General Manager, Research and Development Division since April 2002; General Manager, Corporate Communications Department at IR Group since April 2004 and Vice President since June 2006. Mr. Fujiyoshi has been Director of Eisai Co. Ltd. since June 2009.

Corporate Headquarters*

4-6-10, Koishikawa
Tokyo, -- 112-8088

Japan

Phone: 81 3 3817 3700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4523:JP ¥7,751.00 JPY +98.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥182.0M
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee
Almirall, S.A.
--
Richard Martin Steeves Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
874.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EISAI CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.